• Rankings
    • Jurisdictions
    • Submissions
    • Research+
    • Future Lawyers
  • Firms & Lawyers
    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House
    • In-House Content
    • GC Powerlist
  • Knowledge Centre
    • Data Products
    • Legal Business
    • News & Developments
  • About Us
    • Legal 500
    • FAQs
    • Marketing
    • Careers
    • Contact us
    • Comparative Guides
    • Events
    • Legal 500 TV
    • Deutschland
    • Paris
Skip to content
Legal Business
  • Home
  • Law firms
    • Full list of law firms
    • Comparative Guides
    • Global100
    • Global London
    • LB100
  • In-House
    • In-House
    • United Kingdom
    • All Powerlists
  • International
    • United Kingdom
    • United States
    • Europe
    • Africa
    • Middle East
    • APAC
  • Practice areas
    • All
    • Corporate and M&A
    • Disputes
    • Employment
    • Energy and infrastructure
    • Financial services
    • Private capital
    • Real estate and construction
    • Restructuring
    • Tax
    • TMT
    • White-collar
  • Law firm data
  • Legal 500 data
  • Events
    • Legal Business Awards
    • ESG Awards
    • Enterprise GC
  • Green Ambassadors
    • Europe 2026
    • United States 2026
    • Asia Pacific 2026
    • United Kingdom 2027
    • Methodology
    • Archive
      • Asia Pacific 2025
      • Europe 2025
      • Latin America 2025
      • United Kingdom 2026
      • United Kingdom 2025
      • United States 2025
      • Green Guide EMEA 2024
  • About
  • Newsletter
Law firms

Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’

Sophie Chan
Sophie Chan · 9 February 2024 · 4 min read
Profile Life Sciences Yearbook 2024
Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’

Baker McKenzie’s Jaspreet Takhar on the future of digital health solutions

What made you decide to specialise in life sciences law?

This article is for Legal Business subscribers. Please log in or subscribe to read on.

Related Content

More in this category

M&A perspectives: Melissa Fogarty

Law firmsIman Tribak26 Jun 2024

M&A perspectives: Jennifer Bethlehem

Law firmsIman Tribak26 Jun 2024

M&A perspectives: Lorenzo Corte

Law firmsIman Tribak26 Jun 2024

Sponsored thought leadership: China life sciences – Transaction insights and notable industry trends

Practice areasGuest Blog9 Feb 2024

The Legal 500 view: Healthy competition

Law firmsBen Wheway9 Feb 2024

Life Sciences Yearbook 2024 – Editor’s letter

Practice areasGeorgina Stanley9 Feb 2024

Transatlantic firms outstrip peers on five-year PEP growth, LB100 data reveals

Law firmsAlex Ryan20 Dec 2024

A good time to be mid-tier: private equity interest on the rise as mid-market thrives

Law firmsTom Cox18 Dec 2024

Green City

The LB100 ranked by PEP: firms push partner profits to new heights as associate pay debate rumbles on

Law firmsAlex Ryan18 Dec 2024

Content

  • Law firms
  • In-House
  • International
  • Practice areas
  • Green Ambassadors

Data

  • Law firm data
  • Legal 500 data
  • Global 100
  • LB100

Company

  • About & Contacts
  • Events
  • Newsletter
  • Subscribe

© 2026 Legal Business Magazine

Legalease Ltd, 188 Fleet Street, London, EC4A 2AG

T: +44 (0)20 4604 0667 | E: [email protected]

E: [email protected]

About & Contacts | Privacy Policy | Cookie Policy | Subscriptions